[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bleeding Disorders Market Study 2016-2026, by Segment (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, ), by Market (Hemophilia A, Hemophilia B, ), by Company (Novo Nordisk, Bayer, )

September 2019 | 52 pages | ID: GA5142CBABA2EN
99Strategy

US$ 1,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Bleeding Disorders market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Plasma-derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Others
Company Coverage (Sales data, Main Products & Services etc.):
  • Novo Nordisk
  • Bayer
  • Baxter International
  • Alnylam Pharmaceuticals
  • Pfizer
  • Xenetic Biosciences
  • Bristol-Myers Squibb Company
  • Sanofi
  • Bioverativ
  • Amgen
Major Region Market
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa
1 INDUSTRY OVERVIEW

1.1 Bleeding Disorders Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 BLEEDING DISORDERS MARKET BY TYPE

2.1 By Type
  2.1.1 Plasma-derived Coagulation Factor Concentrates
  2.1.2 Recombinant Coagulation Factor Concentrates
  2.1.3 Desmopressin
  2.1.4 Antifibrinolytics
  2.1.5 Fibrin Sealants
  2.1.6 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Hemophilia A
  3.1.2 Hemophilia B
  3.1.3 Von Willebrand Disease
  3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Novo Nordisk (Company Profile, Sales Data etc.)
5.2 Bayer (Company Profile, Sales Data etc.)
5.3 Baxter International (Company Profile, Sales Data etc.)
5.4 Alnylam Pharmaceuticals (Company Profile, Sales Data etc.)
5.5 Pfizer (Company Profile, Sales Data etc.)
5.6 Xenetic Biosciences (Company Profile, Sales Data etc.)
5.7 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
5.8 Sanofi (Company Profile, Sales Data etc.)
5.9 Bioverativ (Company Profile, Sales Data etc.)
5.10 Amgen (Company Profile, Sales Data etc.)

6 CONCLUSION

LIST OF TABLES

Table Global Bleeding Disorders Market 2016-2019, by Type, in USD Million
Table Global Bleeding Disorders Market 2016-2019, by Type, in Volume
Table Global Bleeding Disorders Market Forecast 2020-2026, by Type, in USD Million
Table Global Bleeding Disorders Market Forecast 2020-2026, by Type, in Volume
Table Global Bleeding Disorders Demand 2016-2019, in USD Million
Table Global Bleeding Disorders Demand 2016-2019, in Volume
Table Global Bleeding Disorders Demand Forecast 2020-2026, in USD Million
Table Global Bleeding Disorders Demand Forecast 2020-2026, in Volume
Table Global Bleeding Disorders Market Size & Growth 2016-2019, in USD Million
Table Global Bleeding Disorders Market Size & Growth 2016-2019, in Volume
Table Global Bleeding Disorders Market Forecast 2020-2026, in USD Million
Table Global Bleeding Disorders Market Forecast 2020-2026, in Volume
Table Global Bleeding Disorders Market 2016-2019, by Region, in USD Million
Table Global Bleeding Disorders Market 2016-2019, by Region, in Volume
Table Global Bleeding Disorders Market Forecast 2020-2026, by Region, in USD Million
Table Global Bleeding Disorders Market Forecast 2020-2026, by Region, in Volume
Table Novo Nordisk Overview List
Table Bleeding Disorders Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Bleeding Disorders Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Bleeding Disorders Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxter International Overview List
Table Bleeding Disorders Business Operation of Baxter International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alnylam Pharmaceuticals Overview List
Table Bleeding Disorders Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Bleeding Disorders Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Xenetic Biosciences Overview List
Table Bleeding Disorders Business Operation of Xenetic Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Bleeding Disorders Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Bleeding Disorders Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bioverativ Overview List
Table Bleeding Disorders Business Operation of Bioverativ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Bleeding Disorders Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Global Bleeding Disorders Market Growth 2016-2019, by Type, in USD Million
Figure Global Bleeding Disorders Market Growth 2016-2019, by Type, in Volume


More Publications